PCM Trials Broadens Clinical Trial Horizons with Strategic Dutch Acquisition

Osborne Clarke, an international law firm with a specialization in life sciences and healthcare, has successfully advised PCM Trials on the acquisition of Clinical Trial Service B.V., a Dutch company prominent in global clinical trials management. PCM Trials, a US-based leader in decentralized clinical trials (DCTs), with this acquisition significantly expands its global operations. The combined entity stands as the most experienced independent provider of mobile visit services, boasting the largest geographic range in support of DCTs. The deal, seen as a strategic move for PCM Trials, allows them to implement a more direct nursing model worldwide. The Osborne Clarke team, led by Herke van Hulst, encompassed expertise across various fields including corporate M&A, tax, data protection, employment, real estate, and regulatory compliance—demonstrating their multidisciplinary approach. This move is indicative of the growing trend in healthcare towards more patient-centric, decentralized clinical trial models and reflects the increasing importance of mobile health services in extending the reach of clinical research.